Table 1 Demographic and clinical characteristics of the study population
Total n = 227 | MDA n = 133 | No MDA n = 94 | p | |
|---|---|---|---|---|
Male, n (%) | 123 (54.2) | 82 (61.7) | 41 (43.6) | <0.05 |
Age, mean (SD), years | 53.2 (12.4) | 53.5 (13.3) | 52.8 (10.9) | NS |
Smoker, n (%) | 41 (18.1) | 19 (14.3) | 22 (23.4) | NS |
Comorbidities, n (%) | ||||
Dyslipemia | 69 (30.4) | 44 (33.1) | 25 (26.6) | NS |
HBP | 62 (27.3) | 35 (26.3) | 27 (28.7) | NS |
Obesity | 48 (21.1) | 32 (24.1) | 16 (17.0) | NS |
DM | 23 (10.1) | 15 (11.3) | 8 (8.5) | NS |
PsA characteristics | ||||
PsA clinical pattern, n (%) | NS | |||
Axial | 8 (3.5) | 3 (2.3) | 5 (5.3) | |
Peripheral | 189 (83.3) | 113 (85.0) | 76 (80.9) | |
Mixed | 30 (13.2) | 17 (12.8) | 13 (13.8) | |
Familial history, n (%) | ||||
Psoriasis | 112 (49.3) | 64 (48.1) | 48 (51.1) | NS |
PsA | 28 (12.3) | 10 (7.5) | 18 (19.1) | <0.05 |
Ankylosing spondylitis | 2 (0.9) | 2 (1.5) | 0 (0.0) | NS |
PsA duration, mean (SD), years | 9.6 (7.7) | 9.80 (8.1) | 9.38 (7.3) | NS |
Skin symptoms duration, mean (SD), years | 22.1 (14.7) | 20.6 (14.3) | 24.2 (15.1) | NS |
Articular symptoms duration, mean (SD), years | 12.1 (9.3) | 11.8 (8.8) | 12.7 (9.9) | NS |
PsA status at study visit | ||||
Radiologic findings | ||||
Erosions in hands, n (%) | 83 (36.6) | 41 (30.8) | 42 (44.7) | <0.05 |
Joint in hands with erosion, mean (SD) | 4.3 (4.2) | 4.9 (4.5) | 3.7 (3.9) | NS |
Erosions in feet, n (%) | 67 (29.5) | 38 (28.6) | 29 (30.9) | NS |
Joint in feet with erosion, mean (SD) | 3.7 (3.4) | 3.9 (3.3) | 3.5 (3.7) | NS |
PsAID, mean (SD) | 4.9 (4.5) | 3.3 (3.1) | 7.1 (5.2)) | <0.001 |
PASI, mean (SD) | 1.6 (3.8) | 0.9 (1.6) | 2.8 (5.7) | <0.05 |
BASDAI*, mean (SD) | 2.8 (2.4) | 2.0 (1.8) | 3.6 (2.5) | <0.001 |
HAQ, mean (SD) | 0.8 (0.6) | 0.3 (0.5) | 0.5 (0.6) | <0.001 |